ASYMPTOTE GENETIC MEDICINES Trademark

Trademark Overview


On Friday, December 20, 2024, a trademark application was filed for ASYMPTOTE GENETIC MEDICINES with the United States Patent and Trademark Office. The USPTO has given the ASYMPTOTE GENETIC MEDICINES trademark a serial number of 98915361. The federal status of this trademark filing is PUBLISHED FOR OPPOSITION as of Tuesday, July 15, 2025. This trademark is owned by Asymptote Genetic Medicines, Inc.. The ASYMPTOTE GENETIC MEDICINES trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Biological research; Biological research and analysis; Development of gene-based medicines; Gene therapy research; Laboratory research services in the field of gene expression; Medical research; Medical research services; Research in the field of gene editing technology; Research in the field of synthetic biology; Software as a service (SAAS) services featuring software using artificial intelligence (AI) for engaging in biological, medical, and gene therapy research; Software as a service (SAAS) services, namely, hosting software for use by others for engaging in biological, medical, and gene therapy research; Providing laboratory research services in the field of gene expression, namely, cancer biology; Testing, inspection, research, or development of pharmaceutical preparations for gene therapy
asymptote genetic medicines

General Information


Serial Number98915361
Word MarkASYMPTOTE GENETIC MEDICINES
Filing DateFriday, December 20, 2024
Status686 - PUBLISHED FOR OPPOSITION
Status DateTuesday, July 15, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, July 15, 2025

Trademark Statements


NOT AVAILABLEGENETIC MEDICINES
Goods and ServicesBiological research; Biological research and analysis; Development of gene-based medicines; Gene therapy research; Laboratory research services in the field of gene expression; Medical research; Medical research services; Research in the field of gene editing technology; Research in the field of synthetic biology; Software as a service (SAAS) services featuring software using artificial intelligence (AI) for engaging in biological, medical, and gene therapy research; Software as a service (SAAS) services, namely, hosting software for use by others for engaging in biological, medical, and gene therapy research; Providing laboratory research services in the field of gene expression, namely, cancer biology; Testing, inspection, research, or development of pharmaceutical preparations for gene therapy

Classification Information


International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateFriday, December 20, 2024
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameAsymptote Genetic Medicines, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressPasadena, CA 91106

Party NameAsymptote Genetic Medicines, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressPasadena, CA 91106

Trademark Events


Event DateEvent Description
Friday, December 20, 2024NEW APPLICATION ENTERED
Sunday, April 27, 2025NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, June 6, 2025ASSIGNED TO EXAMINER
Tuesday, June 10, 2025NON-FINAL ACTION E-MAILED
Tuesday, June 10, 2025NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, June 10, 2025NON-FINAL ACTION WRITTEN
Thursday, June 12, 2025CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, June 13, 2025TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, June 12, 2025TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, June 13, 2025APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, July 9, 2025NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, July 15, 2025PUBLISHED FOR OPPOSITION
Tuesday, July 15, 2025OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED